Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- ABBVIE INC.
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
180 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Framingham Centro Medico /id# 202688
La Plata, Buenos Aires, Argentina
- Instituto de Neumonología Y Dermatología /id# 203444
Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires, Argentina
- Psoriahue Med Interdisciplinar /id# 202451
Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires, Argentina
- Woden Dermatology /id# 205799
Phillip, Australian Capital Territory, Australia
- Holdsworth House Medical Practice /id# 211236
Darlinghurst, New South Wales, Australia
- North Eastern Health Specialists /id# 205802
Hectorville, South Australia, Australia
- Skin Health Institute Inc /id# 204791
Carlton, Victoria, Australia
- Fremantle Dermatology /id# 205305
Fremantle, Western Australia, Australia
- University Clinical Centre of the Republic of Srpska /id# 202666
Banja Luka, Republika Srpska, Bosnia and Herzegovina
- University Clinical Centre of the Republic of Srpska /id# 202667
Banja Luka, Republika Srpska, Bosnia and Herzegovina
- Clinical Center University of Sarajevo /id# 202668
Sarajevo, Bosnia and Herzegovina
- Clinical Center University of Sarajevo /id# 202669
Sarajevo, Bosnia and Herzegovina
- Umhat Dr Georgi Stranski Ead /id# 201521
Pleven, Bulgaria
- Umhat Alexandrovska Ead /id# 201519
Sofia, Bulgaria
- Umhat Professor Stoyan Kirkovich /id# 201522
Stara Zagora, Bulgaria
- Dermatology Research Institute Inc. /id# 200318
Calgary, Alberta, Canada
- Kirk Barber Research, Ca /id# 200324
Calgary, Alberta, Canada
- Dr. Chih-Ho Hong Medical Inc. /id# 200311
Surrey, British Columbia, Canada
- Enverus Medical Research /id# 200307
Surrey, British Columbia, Canada
- Wiseman Dermatology Research /id# 200323
Winnipeg, Manitoba, Canada
- Dr. Irina Turchin Pc Inc. /id# 200322
Fredericton, New Brunswick, Canada
- Karma Clinical Trials /id# 200316
St. John's, Newfoundland and Labrador, Canada
- Hamilton Health Sciences - Mcmaster University Medical Centre /id# 200313
Hamilton, Ontario, Canada
- Dr. Wei Jing Loo Medicine Prof /id# 206051
London, Ontario, Canada
- Lynderm Research Inc. /id# 200315
Markham, Ontario, Canada
- Dermatology Ottawa Research Centre /id# 200319
Ottawa, Ontario, Canada
- K. Papp Clinical Research /id# 200317
Waterloo, Ontario, Canada
- Dr. David Gratton Dermat Inc. /id# 200309
Montreal, Quebec, Canada
- Innovaderm Research Inc. /id# 200320
Montreal, Quebec, Canada
- Dre Angelique Gagne-Henley M.D. Inc. /id# 200326
Saint-Jérôme, Quebec, Canada
- Peking University People'S Hospital /id# 202549
Beijing, Beijing Municipality, China
- Peking University Third Hospital /id# 202612
Beijing, Beijing Municipality, China
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University /id# 208597
Guangzhou, Guangdong, China
- the Third Affiliated Hospital of Sun Yat-Sen University /id# 202548
Guangzhou, Guangdong, China
- the First Hospital of China Medical University /id# 202615
Shenyang, Liaoning, China
- Ruijin Hospital, Shanghai Jiaotong University School of Medicine /id# 202554
Shanghai, Shanghai Municipality, China
- the Second Affiliated Hospital of Zhejiang University School of Medicine /id# 202608
Hangzhou, Zhejiang, China
- Beijing Friendship Hospital /id# 202601
Beijing, China
- Huashan Hospital of Fudan University /id# 205760
Shanghai, China
- Union Hospital Affiliated To Tongji Medical College of Huazhong University of Sc /id# 208598
Wuhan, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 13 Aug 2018
- Primary completion
- 6 Jan 2021
- Completion
- 10 Oct 2025
- Last update posted
- 17 Jun 2026
- Registered enrollment
- 912
- Registry id
- NCT03569293
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.